AstraZeneca
A global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Learn more
Launch date
Employees
Market cap
CAD332.1b
Enterprise valuation
CAD368.2b (Public information from Sep 2024)
Share price
$78.58 AZN
Company register number 03674842
Cambridge England (HQ)
Corporate Venture Fund: AstraZeneca Pharmaceutical
No columns specified